Akèy › Kansè Urojenital
Etid klinik pou Kansè Urojenital ap rekrite nan Etazini
23 etid pou Kansè Urojenital ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX6 etid
- Washington, DC6 etid
- Columbus, OH5 etid
- Nashville, TN5 etid
- Durham, NC4 etid
- St. Louis, MO3 etid
- New York City, NY3 etid
- Miami, FL3 etid
- Queens, NY3 etid
- Orange, CA3 etid
- Dallas, TX3 etid
- Los Angeles, CA3 etid
- Boston, MA3 etid
- Omaha, NE3 etid
- Atlanta, GA3 etid
- Ann Arbor, MI3 etid
- Cedar Rapids, IA3 etid
Pa eta
- Florid6 etid
- Georgia3 etid
- Illinois4 etid
- Iowa3 etid
- Kalifòni10 etid
- Maryland8 etid
- Massachusetts4 etid
- Michigan5 etid
- Minnesota3 etid
- Missouri5 etid
- Nebraska3 etid
- New York4 etid
- North Carolina6 etid
- Ohio7 etid
- South Carolina4 etid
- Tennessee5 etid
- Texas10 etid
- Virginia3 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07215624Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Oct 2, 2026 · NCT01174121Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Ap rekriteFaz 2
Laj 18 a 72 · Tout sèks · Mizajou Sep 28, 2026 · NCT03412877Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06800313Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT04038619Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05997615A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04923178Discharge Medication Use Post-Operatively in GU Cancer Patients
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06795087Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT03819296Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT07103018Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou May 14, 2026 · NCT05413850Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734Feasibility Study of CBCT for IGRT in Cancer Patients
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06681233Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 3, 2026 · NCT07447050Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 20, 2026 · NCT04354064Gender Related Coping and Survivorship for Genitourinary Cancers
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Oct 3, 2025 · NCT05649306Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 15, 2025 · NCT0540616718F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Ap rekriteFaz 4
Laj 18 ak plis · Gason · Mizajou Nov 27, 2024 · NCT06706921Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.